Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

Adele K Fielding

doi:10.1182/asheducation-2011.1.231

Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

Adele K Fielding

The Hull York Medical School

Research output: Contribution to journal › Review article › peer-review

Abstract

The author discusses both the standards of care and more controversial areas in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Original language	English
Pages (from-to)	231-7
Number of pages	7
Journal	Hematology (United States)
Volume	2011
DOIs	https://doi.org/10.1182/asheducation-2011.1.231
Publication status	Published - 2011

Keywords

Drug Resistance, Neoplasm/drug effects
Hematopoietic Stem Cell Transplantation
Humans
Philadelphia Chromosome
Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
Protein Kinase Inhibitors/pharmacology
Remission Induction

Access to Document

10.1182/asheducation-2011.1.231

Cite this

@article{24fd17256c7a4e93b0461902e8525cf9,

title = "Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia",

abstract = "The author discusses both the standards of care and more controversial areas in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.",

keywords = "Drug Resistance, Neoplasm/drug effects, Hematopoietic Stem Cell Transplantation, Humans, Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Protein Kinase Inhibitors/pharmacology, Remission Induction",

author = "Fielding, {Adele K}",

year = "2011",

doi = "10.1182/asheducation-2011.1.231",

language = "English",

volume = "2011",

pages = "231--7",

journal = "Hematology (United States)",

issn = "1520-4391",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia

AU - Fielding, Adele K

PY - 2011

Y1 - 2011

N2 - The author discusses both the standards of care and more controversial areas in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

AB - The author discusses both the standards of care and more controversial areas in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

KW - Drug Resistance, Neoplasm/drug effects

KW - Hematopoietic Stem Cell Transplantation

KW - Humans

KW - Philadelphia Chromosome

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

KW - Protein Kinase Inhibitors/pharmacology

KW - Remission Induction

U2 - 10.1182/asheducation-2011.1.231

DO - 10.1182/asheducation-2011.1.231

M3 - Review article

C2 - 22160039

SN - 1520-4391

VL - 2011

SP - 231

EP - 237

JO - Hematology (United States)

JF - Hematology (United States)

ER -